Morgan Stanley’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $689M | Sell |
|
|||||
|
2025
Q2 | $986M | Buy |
|
|||||
|
2025
Q1 | $855M | Buy |
|
|||||
|
2024
Q4 | $1.05B | Sell |
|
|||||
|
2024
Q3 | $1.71B | Sell |
|
|||||
|
2024
Q2 | $2.09B | Buy |
|
|||||
|
2024
Q1 | $1.54B | Sell |
|
|||||
|
2023
Q4 | $2.2B | Buy |
|
|||||
|
2023
Q3 | $838M | Sell |
|
|||||
|
2023
Q2 | $759M | Buy |
|
|||||
|
2023
Q1 | $732M | Sell |
|
|||||
|
2022
Q4 | $705M | Buy |
|
|||||
|
2022
Q3 | $373M | Buy |
|
|||||
|
2022
Q2 | $408M | Buy |
|
|||||
|
2022
Q1 | $96.1M | Sell |
|
|||||
|
2021
Q4 | $105M | Buy |
|
|||||
|
2021
Q3 | $88.2M | Buy |
|
|||||
|
2021
Q2 | $73.7M | Buy |
|
|||||
|
2021
Q1 | $52M | Sell |
|
|||||
|
2020
Q4 | $78.4M | Buy |
|
|||||
|
2020
Q3 | $63.6M | Sell |
|
|||||
|
2020
Q2 | $60.4M | Buy |
|
|||||
|
2020
Q1 | $49.1M | Buy |
|
|||||
|
2019
Q4 | $45.7M | Sell |
|
|||||
|
2019
Q3 | $43.5M | Buy |
|
|||||
|
2019
Q2 | $41.5M | Sell |
|
|||||
|
2019
Q1 | $44.6M | Buy |
|
|||||
|
2018
Q4 | $38.1M | Sell |
|
|||||
|
2018
Q3 | $42.2M | Sell |
|
|||||
|
2018
Q2 | $43.4M | Sell |
|
|||||
|
2018
Q1 | $49.2M | Buy |
|
|||||
|
2017
Q4 | $51.2M | Sell |
|
|||||
|
2017
Q3 | $59.9M | Buy |
|
|||||
|
2017
Q2 | $46.9M | Sell |
|
|||||
|
2017
Q1 | $49.7M | Buy |
|
|||||
|
2016
Q4 | $51.5M | Sell |
|
|||||
|
2016
Q3 | $125M | Buy |
|
|||||
|
2016
Q2 | $85.9M | Buy |
|
|||||
|
2016
Q1 | $70.7M | Buy |
|
|||||
|
2015
Q4 | $68.9M | Buy |
|
|||||
|
2015
Q3 | $60.1M | Sell |
|
|||||
|
2015
Q2 | $65.5M | Buy |
|
|||||
|
2015
Q1 | $58.4M | Sell |
|
|||||
|
2014
Q4 | $55M | Buy |
|
|||||
|
2014
Q3 | $49.8M | Buy |
|
|||||
|
2014
Q2 | $43.1M | Sell |
|
|||||
|
2014
Q1 | $45.5M | Sell |
|
|||||
|
2013
Q4 | $43.2M | Buy |
|
|||||
|
2013
Q3 | $36.7M | Buy |
|
|||||
|
2013
Q2 | $30.8M | Buy |
|